NEW YORK (GenomeWeb) – Caribou Biosciences today announced that it has closed an $11 million Series A financing round.

Investors included Fidelity Biosciences, Novartis, Mission Bay Capital, 5 Prime Ventures, and one undisclosed partner. Caribou co-founder and pioneering CRISPR/Cas9 researcher Jennifer Doudna has also joined as an investor, the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.